The Oregon Clinical & Translational Research Institute at OHSU has received a $37 million boost from the federal government to help accelerate the translation of research into clinical use, medical practice and health policy.
The National Institutes of Health awarded OCTRI a coveted Clinical and Translational Science Award to support the institute’s work over the next five years.
“Our support for clinical trials, translational science, pilot studies, career development and study design has made OCTRI an essential part of the OHSU research community,” said David Ellison, M.D., the institute’s director. “We look forward to continuing this important work with OHSU investigators.”
The institute’s career development initiatives have educated more than 600 young investigators since 2006, and pilot study funding supports innovation and collaboration throughout OHSU. In addition, the institute also supports clinical research at OHSU by offering informatics, data management and analysis and regulatory assistance.
The institute is part of a national consortium established in 2006 when the predecessor of today’s National Center for Advancing Translational Sciences awarded 12 academic health centers, including OHSU, with Clinical and Translational Science Awards. The program has since expanded to fund institutes at the most prominent academic health centers around the United States, working to improve clinical and translational science.